Jefferies downgraded Pactiv Evergreen (PTVE) to Hold from Buy with a price target of $18, up from $15. The firm cites the sale to Novolex for the downgrade and views the regulatory risk as manageable.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTVE: